![John Josey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Josey
Président chez
Circle Pharma, Inc.
Profil
John A. Josey currently works at Circle Pharma, Inc., as Chairman from 2020, Atavistik Bio, Inc., as Chairman from 2022, VHL Alliance, Inc., as Director, and The Column Group LLC, as Partner.
Dr. Josey also formerly worked at Peloton Therapeutics, Inc., as President, Chief Executive Officer & Director from 2013 to 2019, Nura Bio, Inc., as CEO, CFO, Secretary & Director, Day One Biopharmaceuticals, Inc., as Independent Director from 2020 to 2026, Glaxo, Inc., as Principal from 1991 to 1995, Amgen, Inc., as Principal from 1995 to 1998, and Array BioPharma, Inc., as Vice President-Discovery Chemistry from 2004 to 2011.
Dr. Josey received his undergraduate degree in 1982 from Colorado State University and doctorate degree in 1989 from The University of Texas at Austin.
Postes actifs de John Josey
| Sociétés | Poste | Début |
|---|---|---|
Circle Pharma, Inc.
 Circle Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Président | 20/03/2020 |
Atavistik Bio, Inc.
 Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Président | 01/01/2022 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Private Equity Investor | 01/03/2020 |
VHL Alliance
 VHL Alliance Miscellaneous Commercial ServicesCommercial Services The VHL Alliance is a non-profit organization that aims to improve the quality of life and health outcomes for VHL (Von Hippel-Lindau) patients, families, and caregivers. The organization provides resources and support for patients, caregivers, researchers, and healthcare professionals. The VHL is a genetic disease that can cause tumors to develop in up to 10 different organs throughout a patient's life. The mission of the VHL includes inclusive community building, connections to excellent education and treatment options, and advancements in medical research to achieve this goal. The company is located in the US. | Directeur/Membre du Conseil | - |
Anciens postes connus de John Josey
| Sociétés | Poste | Fin |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 23/04/2026 |
Nura Bio, Inc.
 Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops neuroprotective drugs and therapies | Directeur Général | 17/09/2024 |
| PELOTON THERAPEUTICS, INC. | Directeur Général | 31/07/2019 |
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | 30/08/2011 |
| AMGEN INC. | Corporate Officer/Principal | 31/12/1998 |
Formation de John Josey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Colorado State University
 Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Glaxo, Inc. | |
Circle Pharma, Inc.
Circle Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Nura Bio, Inc.
Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops neuroprotective drugs and therapies | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Health Technology |
VHL Alliance
VHL Alliance Miscellaneous Commercial ServicesCommercial Services The VHL Alliance is a non-profit organization that aims to improve the quality of life and health outcomes for VHL (Von Hippel-Lindau) patients, families, and caregivers. The organization provides resources and support for patients, caregivers, researchers, and healthcare professionals. The VHL is a genetic disease that can cause tumors to develop in up to 10 different organs throughout a patient's life. The mission of the VHL includes inclusive community building, connections to excellent education and treatment options, and advancements in medical research to achieve this goal. The company is located in the US. | Commercial Services |
Choisissez Zonebourse 
